[ad_1]
Insured persons can benefit, as of December 1, from laboratory tests and paraclinical medical investigations throughout the country, based on a referral note issued by doctors in a contractual relationship with one of the health insurance companies, according to a decision. adopted. for the Government, CNAS announced on Tuesday.
Until now, these services could only be provided by paraclinical medical service providers who had a contractual relationship with the same health insurance company as the doctor who issued the referral ticket.
According to a press release from the CNAS, as a result, paraclinical service providers who have entered into two contracts, respectively, with the health insurance company in whose administrative-territorial scope they have their lucrative registered offices, branches or work points. and authorized and with the House for the Defense of Medical Insurance, Public Order, National Security and the Judicial Authority will maintain a contractual relationship with a single health insurance house for which they will choose.
CNAS claims it will be thus reducing the “bureaucracy” in the system, by eliminating the separate records and monthly reports of the services provided to the two insurance companies with which they had contracted.
“This regulation is necessary facilitate the insured’s access to paraclinical investigations recommended by specialist doctors. We hope soon guarantee the same regime of use for medical prescriptions, such that Prescription drugs can be dispensed by any pharmacy in the country. This project is being finalized, but a trial period will be needed to ensure that, once implemented, it operates without syncope, “CNAS president Adela Cojan was quoted as saying.
CNAS reminds that between The documents whose validity has been extended until December 31 include referral tickets for paraclinical specialties, and for the 4th quarter of this year the funds allocated to research were supplemented by 63.7 million lei.
Likewise, in order to facilitate access to paraclinical medical services provided in the specialized outpatient clinic necessary for the follow-up of patients diagnosed with oncological diseases, diabetes, cardiovascular diseases, rare diseases, neurological diseases and cerebrovascular diseases, according to GD 820/2020 , the settlement was regulated. these investigations at the level of realized value.
“Paraclinical investigations are recommended by the specialist doctor for the diagnosis and monitoring of certain diseases. The doctor may decide, as the case may be, to carry out emergency investigations or to issue a referral note from which the patient will go to a provider of paraclinical medical services “.says CNAS.
The Government Decision approved on Monday modifies and completes Annex 2 of the GD. 140/2018 for the approval of the service packages and the Framework Contract that regulates the conditions for the granting of medical assistance, medicines and medical devices within the social health insurance system for the years 2018 – 2019.
Publisher: Georgiana Marina
